NCT05720065View on ClinicalTrials.gov

Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2027

Conditions
Temporomandibular Disorders
Interventions
DRUG

Botulinum toxin type A

Randomized double-blind administration

DRUG

Isotonic saline 0,9%

Randomized double-blind administration

Trial Locations (1)

SE14104

RECRUITING

Department of Dental Medicine, Karolinska Institutet, Huddinge

All Listed Sponsors
lead

Karolinska Institutet

OTHER